JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265441

Human LIN7C knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

LIN7C KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 26 bp deletion in exon 1 and 7 bp insertion in exon 1.

View Alternative Names

LIN 7 protein 3, Lin 7 homolog C (C. elegans), MALS 3, Mammalian lin seven protein 3, Protein lin 7 homolog C, Veli 3, Veli 3 protein, Vertebrate lin 7 homolog 3

3 Images
Sanger Sequencing - Human LIN7C knockout HeLa cell line (AB265441)
  • Sanger seq

Unknown

Sanger Sequencing - Human LIN7C knockout HeLa cell line (AB265441)

Allele-1 : 26 bp deletion in exon 1.

Sanger Sequencing - Human LIN7C knockout HeLa cell line (AB265441)
  • Sanger seq

Unknown

Sanger Sequencing - Human LIN7C knockout HeLa cell line (AB265441)

Allele-2 : 1 bp insertion in exon 1.

Sanger Sequencing - Human LIN7C knockout HeLa cell line (AB265441)
  • Sanger seq

Unknown

Sanger Sequencing - Human LIN7C knockout HeLa cell line (AB265441)

Allele-3 : 7 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and 26 bp deletion in exon 1 and 7 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265441-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265441 Human LIN7C knockout HeLa cell line", "number":"AB265441-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265441-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265441 Human LIN7C knockout HeLa cell line", "number":"AB265441-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LIN7C
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LIN7C also known as Lin-7 homolog C or Veli3 is a protein associated with the regulation of cellular processes. This protein weighs approximately 24 kDa and is expressed in various tissues including the brain and epithelial cells. LIN7C belongs to the LIN-7 family characterized by their PDZ domains which are important for protein-protein interactions. The protein plays a significant role in maintaining cell polarity which is essential for the proper functioning of cells in different tissue types.
Biological function summary

LIN7C contributes significantly to cellular signaling and organization. It operates as part of a multiprotein complex alongside DLG1 and CASK interacting with several other proteins to facilitate cell adhesion and synaptic transmission. This assembly orchestrates the anchoring of membrane proteins influencing the spatial distribution of signaling receptors. LIN7C's role ensures that proteins reach and maintain their proper membrane location important for successful synaptic and epithelial cell functioning.

Pathways

LIN7C is actively involved in the PI3K/AKT pathway critical for cell survival and proliferation. LIN7C assists in stabilizing interactions with signaling molecules like GRIN2B contributing to synaptic plasticity and memory formation. Additionally LIN7C engages with the Wnt signaling pathway which influences cell development and differentiation through interactions with proteins such as LRP6. This interaction emphasizes LIN7C's importance in processes that guide cellular growth and differentiation.

LIN7C has connections to neurological conditions such as autism spectrum disorders and schizophrenia. Its involvement in maintaining synaptic stability and neurotransmission links it to these disorders often characterized by synaptic dysfunction. Moreover dysregulation of LIN7C affects interactions with proteins such as DLG4 contributing to the pathophysiology of these conditions. Understanding LIN7C's role offers insight into potential therapeutic targets for mitigating synaptic-related dysfunctions seen in these neuropsychiatric disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com